Angiogenic factors and the endometrium following long term progestin only contraception

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 167-172

  Lockwood, C J ^a   Schatz, F ^a   Krikun, G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Contraception; Endometrium; Uterine Bleeding

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; GESTAGEN; HEMOSTATIC AGENT; REACTIVE OXYGEN METABOLITE; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; CONTRACEPTION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENDOMETRIAL DISEASE; ENDOMETRIUM; FAMILY PLANNING; HUMAN; LONG TERM CARE; MENSTRUAL CYCLE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; UTERUS BLEEDING;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIUM; FEMALE; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PROGESTINS; TIME FACTORS; UTERINE HEMORRHAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1642555940     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Archer D.F., Philput C.A. and Weber M.E. (1996). Management of irregular uterine bleeding and spotting associated with Norplant. Hum. Reprod. 2 (Suppl 2) 24-30.
2. Bach R.R. (1988). Initiation of coagulation by tissue factor. CRC Crit. Rev. Biochem. 23, 339-368.
3. Belsey E.M. (1998). The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38, 207-225.
4. Browder T., Folkman J. and Pirie-Shepherd S. (2000). The hemostatic system as a regulator of angiogenesis. J. Biol. Chem. 275, 1521-1524.
5. Charnock-Jones D.S., Macpherson A.M., Archer D.F., Leslie S., Makkink W.K. and Sharkey A.M. (2000). The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum. Reprod. 15, (suppl 3), 85-95.
6. Cheung A.H., Stewart R.J. and Marsden P.A. (1998). Endothelial Tie2/Tek ligands angiopoietin-1 (ANGPT1) and angiopoietin-2 (ANGPT2): Regional localization of the human genes to 8q22.3-q23 and 8p23. Genomics 48, 89-91.
7. Classen-Linke I., Alfer J., Krusche C.A., Chwalisz K., Rath W. and Beier H.M. (2000). Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids 6, 763-771.
8. Cui M.Z., Parry G.C.N., Oeth P., Larson H., Smith M., Huang R.P., Adamson E.D. and Mackman N. (1996). Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by SP1 and EGR-1. J. Biol. Chem. 271, 2731-2739.
9. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C. and Yancopoulos G.D. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
10. Donovan-Peluso M., George L.D. and Hasset A.C. (1994). Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells, protein-DNA interactions with the promoter. J. Biol. Chem. 269, 1361-1369.
11. Fan M. and Sujuan G. (1996). Menstrual bleeding patterns in Chinese women using the Norplant subdermal implant. Hum. Reprod. 2 Suppl 2, 14-19.
12. Ferrara N. (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543.
13. Gale N.W. and Yancopoulos G.D. (1999). Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055-1066.
14. Gale N., Thurston G., Hackett S., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M., Jackson D., Suri C., Campochiaro P., Wiegand S. and Yancopoulos G. (2002). Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell. 3, 411-423.
15. Guha A., Bach R., Konigsberg W. and Nemerson Y. (1986). Affinity purification of human tissue factor: Interaction of factor VII and tissue factor in detergent micelles. Proc. Natl. Acad. Sci. USA 83, 299-302.
16. Hague S., MacKenzie I.Z., Bicknell R. and Rees M.C. (2002). In-vivo angiogenesis and progestogens. Hum. Reprod. 17, 786-793.
17. Hickey M. and Fraser I.S. (2000). A functional model for progestogen-induced breakthrough bleeding. Hum. Reprod. 15 Suppl 3, 1-6.
18. Hickey M., Fraser I., Dwarte D. and Graham S. (1996). Endometrial vasculature in NORPLANT users: Preliminary results from a hysteroscopic study. Hum. Reprod. 2: Suppl 2, 35-44.
19. Hickey M., Simbar M., Markham R., Young L., Manconi F., Russell P. and Fraser I.S. (1999). Changes in vascular basement membrane in the endometrium of Norplant users. Hum. Reprod. 14, 716-721.
20. Hickey M., Carati C., Manconi F., Gannon B.J., Dwarte D. and Fraser I.S. (2000). The measurement of endometrial perfusion in Norplant users: A pilot study. Hum. Reprod. 15, 1086-1091.
21. Holash J., Wiegand S.J. and Yancopoulos G.D. (1999). New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18, 5356-5362.
22. Hornung D., Lebovic D.I., Shifren J.L., Vigne J.L. and Taylor R.N. (1988). Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril. 69, 909-915.
23. Krikun G., Critchley H., Schatz F., Wan L., Caze R., Baergen R.N. and Lockwood C.J. (2002). Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression. Am. J. Pathol. 161, 79-86.
24. Krikun G., Schatz F., Finlay T., Kadner S., Mesia A., Gerrets R. and Lockwood C.J. (2000). Expression of angiopoietin-2 by human endometrial endothelial cells: Regulation by hupoxia and inflammation. Biochem. Biophys. Res. Comm. 275, 59-163.
25. Lau T.M., Affandi B. and Rogers P.A. (1999). The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol. Hum. Reprod. 557-563.
26. Lebovic D.I., Shifren J.L., Ryan I.P., Mueller M.D, Korn A.P, Darney P.D. and Taylor R.N. (2000). Ovarian steroid and cytokine modulation of human endometrial angiogenesis. Hum. Reprod. 15, Suppl 3, 67-77.
27. Lockwood C.J., Nemerson Y., Guller S., Krikun G., Alvarez M., Hausknecht V., Gurpide E. and Schatz F. (1993a). Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J. Clin. Endocrinol. Metab. 7, 231-236.
28. Lockwood C.J., Nemerson Y., Krikun G., Hausknecht V., Markiewicz L., Alvarez M., Guller S. and Schatz F. (1993b). Steroid-modulated stromal cell tissue factor expression: A model for the regulation of endometrial hemostasis and menstruation. J. Clin. Endocrinol. Metab. 77, 1014-1019.
29. Lockwood C.J. and Schatz F. (1996). A biological model for the regulation of peri-implantational hemostasis and menstruation. J. Soc. Gynecol. Invest. 3, 159-165.
30. Lockwood C.J., Krikun G., Runic R., Schwartz L.B., Mesia A.F. and Schatz F. (2000). The role of tissue factor in regulating endometrial haemostasis: Implications for progestin-only contraception. Hum. Reprod. 15 (Suppl3) 144-151.
31. Lockwood C.J., Krikun G. and Schatz F. (2001). Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann. NY Acad. Sci. 943, 77-88.
32. Lockwood C.J., Krikun C.J., Koo A.B., Kadner S. and Schatz F. (2002). Differential effects of thrombin and hypoxia on endometrial stromal and glandular epithelial cell vascular endothelial growth factor expression. J. Clin. Endocrinol. Metab. 87, 4280-4286.
33. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J, Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N. and Yancopoulos G.D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
34. Maragoudakis M.E., Tsopanoglou N.E and Andriopoulou P. (2002). Mechanism of thrombin-induced angiogenesis. Biochem. Soc. Trans. 30, 173-177.
35. Moll T., Czyz M., Holzmüller H., Hofer-Warbinek R., Wagner E., Winkler H., Bach F.H. and Hofer E. (1995). Regulation of the tissue factor promoter in endothelial cells, binding of NFkB, AP-1 and SP1-like transcription factors. J. Biol. Chem. 270, 3849-3857.
36. Nemerson Y. (1988). Tissue factor and hemostasis. Blood 71, 1-8.
37. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M. and Honda Y. (1999). Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274, 15732-15739.
38. O'Reilly F.M, Casper K.A., Otto K.B., Sexton S.A. and Swerlick R.A. (2003). Regulation of tissue factor in microvascular dermal endothelial cells. J. Invest. Dermatol. 120, 489-494
39. Pendurthi U.R. and Rao L.V. (2002). Factor VIIa/tissue factor-induced signaling: A link between clotting and disease. Vitam. Horm. 64, 323-355.
40. Peppelenbosch M.P. and Versteeg H.H. (2001). Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends. Cardiovasc. Med. 11, 335-339
41. Peters K.G., DeVries C. and Williams L.T. (1993). Vascular endothelial growth factor receptor expression during embryogenesis and tisue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA 90, 8915-8919.
42. Popovici R.M., Irwin J.C., Giaccia A.J. and Giudice L.C. (1999). Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: Potential relevance to menstruation and endometrial regeneration. J. Clin. Endocrinol. Metab. 84, 2245-2248.
43. Robinson C.J. and Stringer S.E. (2001). The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell. Sci. 114, 853-865.
44. Rogers P.A.W. (1996). Endometrial vasculature in Norplant users. Hum. Reprod. 2 (Suppl 2) 45-50.
45. Rogers P.A., Plunkett D. and Affandi B. (2000). Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding. Hum. Reprod. 15 (Suppl 3) 78-84
46. Runic R., Schatz F., Krey L., Demopoulos R., Thung S., Wan L. and Lockwood C.J. (1997). Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception. J. Clin. Endocrinol. Metab. 82, 1983-1988.
47. Runic R., Schatz F., Wan L., Demopoulos R., Krikun G., and Lockwood C.J. (2000). Effects of norplant on endometrial tissue factor expression and blood vessel structure. J. Clin. Endocrinol. Metab. 85, 3853-3859.
48. Ruf W. and Mueller B.M. (1996). Tissue factor in cancer angiogenesis and metastasis. Curr. Opin. Hematol. 3, 379-384.
49. Senger D.R., Ledbetter S.R., Claffey K.P., Papadopoulos-Sergiou A., Peruzzi C.A. and Detmar M. (1996). Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149, 293-305
50. Sharkey A.M., Day K., McPherson A., Malik S., Licence D., Smith S.K. and Charnock-Jones DS. (2000). Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J. Clin. Endocrinol. Metab. 85, 402-409.
51. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N., Jaffe R.B. and Taylor R.N. (1996). Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol Metab. 81, 3112-3118.
52. Shoji M., Hancock W.W. and Abe K. (1998). Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am. J. Pathol. 152, 399-411.
53. Smith S.K., Torry D.S., Holt V.J., Keenan J.A., Harris G., Caudle M.R. and Torry R.J. (1996). Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril. 66, 72-80
54. Smith S.K. (1988). Angiogenesis, vascular endothelial growth factor and the endometrium. Hum. Reprod. Update 4, :509-519.
55. Stenina O.I. (2003). Regulation of gene expression in vascular cells by coagulation proteins. Curr. Drug. Targets 4, 143-158.
56. Su-Juan G., Ming-Kun D., Ling-De Z., Ying-Lin L., Shu-Hua W. and Sivin I. (1994). A 5-year evaluation of NORPLANT contraceptive implants in China. Obstet. Gynecol. 83, 673-678.
57. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N and Yancopoulos G.D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
58. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N. and Yancopoulos G.D. (1999). Increased vascularization in mice overexpressing angiopoietin-1. Science 282, 468-471.
59. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C. and Abraham J.A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
60. Torry D.S., Holt V.J., Keenan J.A., Harris G., Caudle M.R. and Torry R.J. (1996). Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril. 66, 72-80.
61. Torry D.S. and Torry R.J. (1997). Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am. J. Reproductiv. Immunol. 37, 21-29.
62. Tsopanoglou N.E. and Maragoudakis M.E. (1999). On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by upregulation of its receptors. J. Biol. Chem. 274, 23969-23976.
63. Valenzuela D.M., Griffiths J.A., Rojas J., Aldrich T.H., Jones P.F., Zhou H., McClain J., Copeland N.G., Gilbert D.J., Jenkins N.A., Huang T., Papadopoulos N., Masonpierre P.C., Davis S. and Yancopoulos G.D. (1999). Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 96, 1904-1909.
64. Versteeg H.H., Peppelenbosch M.P. and Spek C.A. (2001). The pleiotropic effects of tissue factor: A possible role for factor VIIa-induced intracellular signaling? Thromb. Haemost. 86, 1353-1359
65. Ward N.L and Dumont D.J. (2002). The angiopoietins and Tie2/Tek: Adding tot he complexity of cardiovascular development. Semin. Cell. Dev. Biol. 13, 19-27.
66. Yokoyama Y., Sato S., Futagami M., Fukushi Y., Sakamoto T., Umemoto M. and Saito Y. (2000). Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. Gynecol. Oncol. 77, 413-418.
67. Zhang L., Scott P.A., Turley H., Leek R., Lewis C.E., Gatter K.C, Harris A.L, Mackenzie I.Z, Rees M.C. and Bicknell R. (1998). Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium. J. Pathol. 185, 402-408.